在清细胞细胞癌中SPOCD1表达:它对预后和免疫疗法的影响
Wu Xu1, Lingfei Yan1, Yufeng Liu1
1Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, 510900, China.
World journal of surgical oncology
|October 15, 2025
概括
SPOCD1过度表达与清细胞脏细胞癌 (ccRCC) 的生存率低下和免疫细胞透率增加有关. 这表明SPOCD1可能作为ccRCC患者的预后指标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- SPOCD1在致癌过程中的作用正在出现.
- 它与清细胞细胞癌 (ccRCC) 预后和免疫透的具体相关性尚不清楚.
研究的目的:
- 调查SPOCD1表达和ccRCC患者存活率之间的关联.
- 在ccRCC中探索SPOCD1和瘤透免疫细胞 (TIICs) 之间的关系.
主要方法:
- 利用TCGA,GEPIA和UALCAN数据库进行表达和生存分析.
- 在TIIC分析中使用了TIMER,GEPIA和TISIDB.
- 在ccRCC细胞系和组织中通过qRT-PCR,西部斑块和免疫组织化学验证了SPOCD1表达.
主要成果:
- SPOCD1表达与TNM阶段,病理阶段和组织学等级相关.
- 升高的SPOCD1预测疾病特异性生存率 (DSS) 和整体生存率 (OS) 较差.
- SPOCD1的过度表达与巨细胞,调节性T细胞 (Treg),Th1,树突细胞 (DC) 和Th2细胞以及免疫调节剂/化学因子的透增加有关.
结论:
- SPOCD1是ccRCC的潜在预后生物标志物.
- 高SPOCD1表达表明不良的临床病理特征,较差的存活率,以及在ccRCC中增加的免疫细胞透.
更多相关视频
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
10.2K
07:59Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
Published on: December 5, 2020
3.0K
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
